US Stock MarketDetailed Quotes

AVTE Aerovate

Watchlist
  • 2.530
  • 0.0000.00%
Close Dec 20 16:00 ET
  • 2.530
  • 0.0000.00%
Post 20:01 ET
73.14MMarket Cap-0.85P/E (TTM)

About Aerovate Company

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.

Company Profile

SymbolAVTE
Company NameAerovate
Listing DateJun 30, 2021
Issue Price14.00
Founded2018
CEOMr. Timothy P. Noyes
MarketNASDAQ
Employees51
Fiscal Year Ends12-31
Address930 Winter Street,Suite M-500
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-617-443-2400
Websitehttp://www.aerovatetx.com

Company Executives

  • Name
  • Position
  • Salary
  • Timothy P. Noyes
  • Director and Chief Executive Officer
  • 3.07M
  • Dr. Benjamin T. Dake, PhD
  • President, Chief Operating Officer and Secretary
  • --
  • Ralph Niven,PhD
  • Chief Scientific Officer
  • --
  • Dr. Marinus Verwijs, PhD
  • Chief Technical Officer
  • --
  • Dr. Hunter Gillies, M.B.
  • Chief Medical Officer
  • --
  • George A. Eldridge
  • Chief Financial Officer, Treasurer and Principal Accounting Officer
  • 2.13M
  • Timothy J. Pigot
  • Chief Commercial Officer
  • 2.45M
  • Mark T. Iwicki
  • Chairman of the Board
  • 218.30K
  • Dr. David S. Grayzel, M.D.
  • Independent Director
  • 225.99K
  • Donald J. Santel
  • Independent Director
  • 568.54K
  • Allison Dorval
  • Independent Director
  • 185.80K
  • Habib Joseph Dable
  • Independent Director
  • 363.25K
  • Dr. Joshua Resnick, M.B.A.,M.D.
  • Independent Director
  • 174.80K
Heat List
US
Overall
Symbol
Price
% Chg

No Data